Skip to main content
. 2004 Feb 11;101(8):2518–2523. doi: 10.1073/pnas.0307318101

Fig. 4.

Fig. 4.

Erythrocyte-binding specificity of RVNQN variant from JESEBL. Lane 1, immunoprecipitate of eluate of untreated human erythrocytes. Lane 2, immunoprecipitate of eluate of trypsin-treated human erythrocytes. Lane 3, immunoprecipitate of eluate of chymotrypsin-treated human erythrocytes. Lane 4, immunoprecipitate of eluate of neuraminidase-treated human erythrocytes.